Cancer Aleksia Therapeutics divulges new CDK4 inhibitors Dec. 9, 2025 Aleksia Therapeutics Inc. has synthesized cyclin-dependent kinase 4 (CDK4) inhibitors reported to be useful for the treatment of breast cancer.Read More
Cancer Aleksia Therapeutics discovers new CDK2/cyclin E1 inhibitors Dec. 12, 2024 Aleksia Therapeutics Inc. has described CDK2/cyclin E1 inhibitors reported to be useful for the treatment of cancer.Read More
